Although future studies are needed, the proposed link between the type I IFN pathway, G-CSF responsiveness, and the myeloid bias of circulating CD34+ cells provide important pathophysiological insights into their behavior post-engraftment in gene therapy settings as well as their involvement in the initiation and persistence of chronic inflammation in patients with SCA. This evidence concerns the gene CSF3 and autosomal dominant cerebellar ataxia.